Sign in

CIK 0001799448

  • Non-accelerated filer
  • Smaller reporting company

Aligos Therapeutics, Inc.

Sign in to watch
Ticker
ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 800-466-6059
Business address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +122,601 122,601
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +13,671 13,671
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +13,671 13,671
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +50,712 91,728
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +3,394 17,065
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +3,394 17,065
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +21,695 113,423
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +1,452 18,517
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +1,452 18,517
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series A Preferred Stock −41,016 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series A Preferred Stock −122,601 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series A Preferred Stock −13,671 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series A Preferred Stock −13,671 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series B-1 Preferred Stock −50,712 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series B-1 Preferred Stock −3,394 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series B-1 Preferred Stock −3,394 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series B-2 Preferred Stock −21,695 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series B-2 Preferred Stock −1,452 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series B-2 Preferred Stock −1,452 0

Page 2 of 2 · 39 trades